Mark A. Wainberg is Professor of Medicine and Microbiology and Immunology at McGill University in Montreal, Canada, where he also serves as Director of the McGill University AIDS Centre. Dr. Wainberg is an internationally recognized scientist in the field of HIV/AIDS. He served as President of the International AIDS Society between 1998-2000 with responsibilities that included organization of the XIIIth International Congress on AIDS in Durban, South Africa, 2000. Dr. Wainberg is proud of the role that he played in the choice of South Africa as a venue for this congress, which had an important impact on the issue of access to anti-HIV drugs in developing countries. He is well-known for his initial identification of 3TC as an anti-viral drug, in collaboration with BioChem Pharma Inc, in 1989, as well as for multiple contributions to the field of HIV drug resistance. His laboratory continues to work in the field of drug development, and, as well, Dr. Wainberg has now turned his attention to novel concepts in prevention of HIV infection in developing countries, such as vaginal microbicides and pre-exposure prophylaxis. He was co-Chair of the XVIth International AIDS Conference that took place in Toronto between August 13-18, 2006. Dr. Wainberg is also a member of numerous international advisory committees in the field of AIDS. He was Chair of the Scientific Council of the ANRS (Agence Nationale de Recherche sur le SIDA) (National Agency for AIDS research of France) until 2008. Dr. Wainberg is an elected fellow of the Royal Society of Canada and is an Officer of the Order of Canada. He is also an Officer of the Ordre National du Québec, a Chevalier in the Legion d’Honneur of France and is an Honorary Fellow of the Royal College of Physicians and Surgeons of Canada. Dr. Wainberg is an author of over 400 research papers and 100 reviews and commentary articles that have appeared in the scientific literature, and is the corresponding author on most of these. He also frequently contributes Op-Ed articles on the topic of AIDS to newspapers in Canada and the U.S.A.